Sodium Citrate Blood Specimen Collection Tubes (Light Blue Top Tube Sodium Citrate) Market By End-User ( Hospitals, Diagnostic Centers, Medical Clinics, and Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 - 2028

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 250

The global sodium citrate blood specimen collection tubes market is expected to grow at a CAGR of around 7.6% from 2021 to 2028.

Sodium citrate blood specimen collection tubes, also known as light blue top tubes contain sodium citrate as an anticoagulant. This tube is specifically used for preparing citrated plasma for coagulation studies. They must be completely filled to ensure a proper anticoagulant-to-blood ratio, and they must be inverted immediately after filling to prevent clotting. Furthermore, sodium citrate blood specimen collection tubes assess the blood's ability to clot as well as the body's ability to sustain a clot. This test determines the likelihood of excessive bleeding or the formation of clots (thrombosis) in blood vessels.

Key growth factor: 

Big calls for sodium citrate blood specimen collection tubes in times of COVID-19 ultimately fuel the demand for the overall market

According to a report published in June 2021 by the College of American Pathologists (CAP), sodium citrate blood specimen collection tubes were in short supply by 3.2% (light blue top tubes). A shortage of these tubes has occurred as a result of several recalls, as well as unprecedented demand for citrate products due to an increase in COVID-19 infection rates. The CAP met with officials from the US Food and Drug Administration to discuss recommendations for addressing the shortage of 3.2% sodium citrate blood specimen collection tubes (USFDA). However, the light blue top tubes will be in short supply for the rest of 2021. Because the supply of sodium citrate blood specimen collection tubes is not expected to meet demand until the end of the year, the Food and Drug Administration (FDA) issued a letter to healthcare providers identifying the Emergency Use Authorization (EUA) granted to Becton Dickinson (BD) for specific sodium citrate blood specimen collection tubes for emergency use in healthcare settings for coagulation testing. Such factors contribute to the overall growth of the sodium citrate blood specimen collection tube market.

Rising prevalence of blood clotting disorders (Venous Thromboembolism) propel the demand for global sodium citrate blood specimen collection tube market

According to the US Department of Health and Human Services, the exact number of people affected by Deep vein thrombosis (DVT) is unknown, but as many as 900,000 people (1 to 2 per 1,000) may be affected annually in the US. According to estimates, 60,000-100,000 Americans die of DVT each year, with 10-30% dying within one month of diagnosis. The coagulopathies and thrombotic complications associated with COVID-19 infection, according to a report published by the American Society of Hematology, pinpoint the surge in demand for coagulation testing. This occurred in the context of a simultaneous global shortage of sodium citrate, the key component in the light blue top tubes. As demand increased, so did available supply and production capacity. As a result, prudent medical decisions reduce demand for light blue top tubes in order to avoid a disastrous interruption in our ability to evaluate and care for patients. Such factors have a positive impact on the sodium citrate blood specimen collection tube market's overall growth.

Fast product approvals by the government further bolster the demand and mitigate shortages in the worldwide market

According to the Centers for Disease Control and Prevention (CDC), shortages of sodium citrate blood specimen collection tubes have occurred as a result of several product recalls combined with increased demand for citrate products as a result of COVID-19 infection rates, COVID-19 vaccines, and treatment development. However, because sodium citrate blood specimen collection tubes supplies are insufficient to meet demand, several strategy recommendations guide clinical laboratories and federal regulators in minimizing the clinical impact of these shortages. For the record, in July 2021, the US Food and Drug Administration (FDA) issued an emergency authorization for imported Becton Dickinson Sodium Citrate Blood Specimen Collection (Light Blue Top) Tubes (BD). Such factors are responsible for the global market's phenomenal growth.

Big players are racing to design innovative products to grab dominant share for the overall market

According to the IBMS report, manufacturers designed light blue top tubes with different color lids for good reasons. For good reason, different colors represent different additives. These various colors represent various additives contained within the tubes, and they are denoted by international standards (ISO 6710:2017). These designs preserve and protect the integrity of blood samples prior to, during, and after analysis. Furthermore, tube manufacturers provide a fixed and validated volume of sodium citrate to be mixed with the patient's blood at a specific 1:9 ratio (citrate solution to whole blood). For example, tubes manufactured by BD, which are the most trusted tubes used for a variety of operations, typically have a frosted line in the plastic that is a minimum fill line. This may be the nominal (i.e. 100% full) line in other tubes, rather tubes manufactured by other manufacturers. These factors contribute to the overall growth of the sodium citrate blood specimen collection tubes market.  

Market Segmentation

The global sodium citrate blood specimen collection tubes market is segmented based on end-user. By end-user, the market is segregated as hospitals, diagnostic centers, medical clinics, and among others

According to end-user, the hospitals segment has shown accelerating growth in the past and is expected to continue in the future. Because there is a high demand from hospitals for sodium citrate blood specimen collection tubes to collect, transport, and store blood samples for coagulation testing, it is regarded as one of the key factors driving segmental growth, which in turn drives overall market growth.

Regional Overview

Asia Pacific will dominate the market for sodium citrate blood specimen collection tubes. With the rise in prevalence of blood clotting disorders in Asia Pacific region rises, so will the demand for sodium citrate blood specimen collection tubes, ultimately resulting in propelling the growth of global market in the coming years. This is one of the most important factors contributing to the growth of the regional market, which in turn contributes to the overall market growth.

Market Participants

The players involved in the sodium citrate blood specimen collection tubes market focused on various growth strategies through launching new products, for expansion of product portfolio and gain competitive lead in the worldwide market. The prominent players responsible for the growth of sodium citrate blood specimen collection tubes market are Becton Dickinson (BD), Greiner Bio-One International GmbH, CML Biotech (P) Ltd., Laboratory Corporation of America®, Neu Micromed International Pvt. Ltd., FL MEDICAL s.r.l., AdvaCare Pharma, and among others

Market Segmentation

Market by End-User

  • Hospitals
  • Diagnostic Centers 
  • Medical Clinics
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil 
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

Sodium citrate blood specimen collection tubes, also known as light blue top tubes contain sodium citrate as an anticoagulant. This tube is specifically used for preparing citrated plasma for coagulation studies.

The sodium citrate blood specimen collection tube is expected to grow at a CAGR of around 7.6% from 2021 to 2028.

Favorable government support for product clearance is one of the prominent factors that drive the demand for sodium citrate blood specimen collection tube.

Becton Dickinson (BD), Greiner Bio-One International GmbH, CML Biotech (P) Ltd., Laboratory Corporation of America®, Neu Micromed International Pvt. Ltd., FL MEDICAL s.r.l., AdvaCare Pharma, and among others.

Cart Summary